ICD-10-CM Billable Code

D36.9

Benign neoplasm, unspecified site

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign neoplasm, unspecified site (ICD-10 code D36.9), refers to a non-cancerous growth that develops in various parts of the body without a specific location identified. These growths are characterized by abnormal cell proliferation but do not invade nearby tissues or metastasize. While often benign, they require proper diagnosis and management to prevent potential complications or misdiagnosis.

Causes & Symptoms

Clinical Causes: Genetic factors that predispose individuals to tumor development. Environmental exposures such as radiation or certain chemicals. Chronic inflammation or irritation in tissues. Hormonal imbalances that stimulate cell growth. Unknown factors; often idiopathic with no clear cause.

Key Symptoms: Presence of a palpable lump or mass in the affected area. Painless swelling or bump that may be slow-growing. Skin changes like discoloration or ulceration over the tumor. Discomfort or localized pain if the tumor presses on nearby structures. No symptoms in some cases, with detection occurring incidentally through imaging.

Diagnostic & Treatment

Diagnosis Path: Medical history review and physical examination focusing on the detected mass. Imaging tests such as ultrasound, MRI, or CT scans to evaluate size, location, and characteristics. Biopsy procedures to obtain tissue samples for histopathological analysis. Laboratory tests if specific markers are suspected to be involved. Exclusion of malignant neoplasms through thorough investigation and imaging.

Treatment Protocols: Surgical excision to remove the benign growth if it causes symptoms or cosmetic concerns. Monitoring the tumor over time with regular imaging if it remains asymptomatic and benign. Medications are rarely used but may include anti-inflammatory drugs if associated with irritation. Addressing underlying causes or contributing factors when identified. Follow-up assessments to detect any recurrence or changes in the tumor's characteristics.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D36.9 a billable ICD-10 code?
Yes, D36.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D36.9?
Clinical documentation must specify the nature of Benign neoplasm, unspecified site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference